Evidence map›Paper›PMID 33924572›Full record

Observational studyNutrients2021

Significant Impact of Coffee Consumption on MR-Based Measures of Cardiac Function in a Population-Based Cohort Study without Manifest Cardiovascular Disease.

Ebba Beller, Roberto Lorbeer, Daniel Keeser, Franziska Galiè, Felix G Meinel, Sergio Grosu, Fabian Bamberg, Corinna Storz, Christopher L Schlett, Annette Peters and 6 more

Abstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ebba BellerInstitute of Diagnostic and Interventional Radiology, Pediatric Radiology and Neuroradiology, University Medical Center Rostock, 18057 Rostock, Germany.
Roberto LorbeerDepartment of Radiology, University Hospital, LMU Munich, 81377 Munich, Germany.
Daniel KeeserDepartment of Radiology, University Hospital, LMU Munich, 81377 Munich, Germany.ORCID 0000-0002-0244-1024
Franziska GalièDepartment of Radiology, University Hospital, LMU Munich, 81377 Munich, Germany.
Felix G MeinelInstitute of Diagnostic and Interventional Radiology, Pediatric Radiology and Neuroradiology, University Medical Center Rostock, 18057 Rostock, Germany.
Sergio GrosuDepartment of Radiology, University Hospital, LMU Munich, 81377 Munich, Germany.
Fabian BambergDepartment of Diagnostic and Interventional Radiology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Corinna StorzDepartment of Neuroradiology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79098 Freiburg, Germany.
Christopher L SchlettDepartment of Diagnostic and Interventional Radiology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Annette PetersInstitute of Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health (GmbH), 85764 Neuherberg, Germany.
Alexandra SchneiderInstitute of Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health (GmbH), 85764 Neuherberg, Germany.ORCID 0000-0002-1084-2442
Jakob LinseisenIndependent Research Group Clinical Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany.ORCID 0000-0002-9386-382X
Christa MeisingerLudwig-Maximilians Universität München, UNIKA-T Augsburg, 86156 Augsburg, Germany.
Wolfgang RathmannGerman Diabetes Center, Institute of Biometrics and Epidemiology, Leibniz Institute at Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.
Birgit Ertl-WagnerDepartment of Medical Imaging, The Hospital for Sick Children, University of Toronto, Toronto, ON M5G 1X8, Canada.
Sophia StoeckleinDepartment of Radiology, University Hospital, LMU Munich, 81377 Munich, Germany.

Funding

Deutsche Forschungsgemeinschaft 245222810
6 · The paper itself

Abstract

Subclinical effects of coffee consumption (CC) with regard to metabolic, cardiac, and neurological complications were evaluated using a whole-body magnetic resonance imaging (MRI) protocol. A blended approach was used to estimate habitual CC in a population-based study cohort without a history of cardiovascular disease. Associations of CC with MRI markers of gray matter volume, white matter hyperintensities, cerebral microhemorrhages, total and visceral adipose tissue (VAT), hepatic proton density fat fraction, early/late diastolic filling rate, end-diastolic/-systolic and stroke volume, ejection fraction, peak ejection rate, and myocardial mass were evaluated by linear regression. In our analysis with 132 women and 168 men, CC was positively associated with MR-based cardiac function parameters including late diastolic filling rate, stroke volume (

Indexed as

AdiposityAgedAlcohol DrinkingBrainCardiovascular DiseasesCoffeeDrinkingFemaleFollow-Up StudiesGermanyHeartHeart Disease Risk FactorsHumansIntra-Abdominal FatLiverMagnetic Resonance ImagingCoffeecardiac functioncoffeemagnetic resonance imagingvisceral adipose tissue

Identifiers

PMID33924572
PMCPMC8069927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.